ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

MESO Mesoblast Limited

5.11
0.10 (2.00%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Mesoblast Limited MESO NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
0.10 2.00% 5.11 09:43:46
Open Price Low Price High Price Close Price Previous Close
4.95 4.77 5.20 5.11 5.01
more quote information »

Recent News

Date Time Source Heading
27/3/202400:25APSFDA Commentary Sends Biotech Soaring During Premarket Hours
26/3/202413:34GLOBEUnited States Food & Drug Administration (FDA) Notifies..
14/3/202410:30GLOBEMesoblast Successfully Completes Placement and Accelerated..
11/3/202410:54GLOBEUnited States Food & Drug Administration (FDA) Supports..
29/2/202409:57GLOBEMesoblast Reports Financial Results and Operational Update..
26/2/202423:00GLOBEMesoblast Financial Results and Corporate Update Webcast
15/2/202411:46GLOBEUnited States Food & Drug Administration (FDA) Grants..
01/2/202413:34EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202413:13GLOBEAppendix 4C Quarterly Activity Report for Quarter Ended..
19/1/202411:28DJNMesoblast Gets FDA's Special Pediatric Designation for..
19/1/202410:36GLOBEUnited States Food & Drug Administration (FDA) Grants..
16/1/202422:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/1/202413:57EDGAR2Form F-6 POS - Post-effective amendments for immediately..
23/12/202309:13EDGAR2Form F-6 POS - Post-effective amendments for immediately..
27/11/202310:56GLOBEMesoblast Files for Orphan Drug and Pediatric Rare Disease..
23/11/202305:35APSBiotech Shares Soar Following Major Announcement
22/11/202310:32GLOBEMesoblast Partners With Blood and Marrow Transplant Clinical..
31/10/202311:04GLOBEAppendix 4C Quarterly Activity Report for Quarter Ended..
26/9/202320:18GLOBEJane Bell AM Appointed Chair of Mesoblast Audit and Risk..
21/9/202317:30GLOBEKey Outcomes From FDA Type A Meeting and Mesoblast Next..
06/9/202320:42EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/8/202309:07GLOBEMesoblast Reports Financial Results and Operational Update..
29/8/202321:00GLOBEMesoblast Financial Results and Corporate Update Webcast
04/8/202323:03DJNMesoblast ADSs Plunge Premarket on Latest FDA Rejection
04/8/202310:10GLOBEMesoblast Receives Complete Response From U.S. Food and Drug..
31/7/202310:31GLOBEAppendix 4C Quarterly Activity Report for Quarter Ended June..
05/6/202310:21GLOBEMesoblast Director Philip R. Krause, M.D., Appointed to..
26/5/202309:28GLOBEMesoblast Reports Operational and Financial Highlights for..
24/5/202321:00GLOBEMesoblast Financial Results and Corporate Update Webcast
28/4/202311:00GLOBEAppendix 4C Quarterly Activity Report
26/4/202310:47GLOBEMesoblast Completes Private Placement

Your Recent History

Delayed Upgrade Clock